Ones and Tooze

Latest Episodes:

The Economics of a Bridge Disaster Apr 05, 2024

Show notes

It will cost up to $3 billion to replace the Francis Scott Key Bridge in the U.S. city of Baltimore, Maryland, which collapsed last month after it was struck by a container ship. Adam and Cameron discuss the implications for the city of Baltimore, the insurance industry, and global shipping.

Also on the show: The economics of Tajikistan.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Economic Thinking of Pope Francis Mar 29, 2024

Show notes

To mark the Easter holiday, Adam and Cameron discuss the economic thinking of Pope Francis and how it strays from the traditional approach of the Catholic Church.

Brought to you by:

betterhelp.com/onestooze

crashplan.com/ones

Learn more about your ad choices. Visit megaphone.fm/adchoices

COVID-19’s Long Shadow, Part 4 Mar 22, 2024

Show notes

This is the fourth installment of a mini series on the long shadow of COVID-19, marking four years since the start of the coronavirus. In this final segment, Adam and Cameron discuss whether the world is now better equipped to respond to similar crises.

Also on the show: The economics of resort hotels.

Learn more about your ad choices. Visit megaphone.fm/adchoices

COVID-19’s Long Shadow, Part 3 Mar 15, 2024

Show notes

To mark four years since the start of the COVID-19 pandemic, Adam and Cameron are talking about the long shadow of the coronavirus. In Part 3, they look at how the pandemic affected the global economy.

Also on the show: China's economy is facing a major rebalancing. Can it keep rising?

Learn more about your ad choices. Visit megaphone.fm/adchoices

COVID-19’s Long Shadow, Part 2 Mar 08, 2024

Show notes

To mark four years since the start of the COVID-19 pandemic, Adam and Cameron are talking about the long shadow of the coronavirus. In Part 2, they look at the economic impact of long COVID—which afflicts about 10 percent of people who contract the coronavirus.

Also on the show, coinciding with the night of the Oscars: The economics of Oppenheimer’s Manhattan Project—the U.S. endeavor to build the first nuclear bomb.

Learn more about your ad choices. Visit megaphone.fm/adchoices

COVID-19’s Long Shadow Mar 01, 2024

Show notes

To mark four years since the start of the COVID-19 pandemic, Adam and Cameron are launching a miniseries: four episodes on the long shadow of the coronavirus. In Part 1, they look at its impact on the commercial real estate market.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Age of American Gerontocracy Feb 23, 2024

Show notes

The United States’ top leaders are older than ever. Is capitalism inherently gerontocratic? Do older leaders govern better or worse historically? And could a leader’s advanced age sap economic confidence and have a pocketbook effect? Adam and Cameron dig in.

Brought to you by: betterhelp.com/onestooze

Learn more about your ad choices. Visit megaphone.fm/adchoices

Indonesia's Presidential Election Feb 16, 2024

Show notes

Prabowo Subianto is on track to win the presidential election in Indonesia, raising concerns about a backslide towards authoritarianism in the world's third largest democracy. Adam and Cameron discuss the political and economic implications.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Who Will Pay to Save Ukraine? Feb 09, 2024

Show notes

In today’s episode, Adam and Cameron look at the political realities as they assess both the United States’ and the European Union’s willingness to continue funding Ukraine’s efforts to defend itself against Russia.

In the second segment, the two take a historic look back at how Las Vegas became Sin City and whether or not having a “fun” economy is beneficial to residents in the long term.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Danish Company Behind Ozempic Feb 02, 2024

Show notes

The market value of Novo Nordisk, the Danish company that makes the weight loss drugs Wegovy and Ozempic, hit $500 billion this past week—a rare achievement for a European firm. Novo Nordisk is owned by a non-profit foundation, which gives the company an unusual corporate structure. Adam and Cameron discuss.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected